These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17036412)

  • 21. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis.
    Chung BJ; Akst LM; Koltai PJ
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1911-7. PubMed ID: 16919339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of dysplasia in juvenile-onset recurrent respiratory papillomatosis.
    Sajan JA; Kerschner JE; Merati AL; Osipov V; Szabo S; Blumin JH
    Arch Otolaryngol Head Neck Surg; 2010 Jan; 136(1):7-11. PubMed ID: 20083770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggressive recurrent respiratory papillomatosis in a neonate.
    Loyo M; Pai SI; Netto GJ; Tunkel DE
    Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):917-20. PubMed ID: 18423627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children.
    Bielecki I; Mniszek J; Cofała M
    Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):681-4. PubMed ID: 19193450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children].
    Pontes P; Weckx LL; Pignatari SS; Fujita RR; Avelino MA; Sato J
    Rev Assoc Med Bras (1992); 2009; 55(5):581-6. PubMed ID: 19918660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis?
    Sheahan P; Sexton S; Russell JD
    J Laryngol Otol; 2006 Jul; 120(7):561-5. PubMed ID: 16834805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic cidofovir in papillomatosis.
    Van Valckenborgh I; Wellens W; De Boeck K; Snoeck R; De Clercq E; Feenstra L
    Clin Infect Dis; 2001 Feb; 32(3):E62-4. PubMed ID: 11170974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cidofovir: to use or not to use?
    Soma MA; Albert DM
    Curr Opin Otolaryngol Head Neck Surg; 2008 Feb; 16(1):86-90. PubMed ID: 18197029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current treatment for laryngeal papillomatosis.
    Kendall KA
    Curr Opin Otolaryngol Head Neck Surg; 2004 Jun; 12(3):157-9. PubMed ID: 15167022
    [No Abstract]   [Full Text] [Related]  

  • 30. Intralesional cidofovir for recurrent respiratory papillomatosis in children.
    Pransky SM; Magit AE; Kearns DB; Kang DR; Duncan NO
    Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1143-8. PubMed ID: 10522508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intralesional cidofovir in severe juvenile respiratory papillomatosis.
    Ablanedo-Terrazas Y; Soda-Merhy A; Hernández-Palestina M; Ormsby CE; Reyes-Terán G
    B-ENT; 2012; 8(3):197-202. PubMed ID: 23113383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment results in adult-onset recurrent respiratory papillomatosis.
    Verguts MM; Genbrugge E; de Jong FI
    B-ENT; 2009; 5(3):137-41. PubMed ID: 19902848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should intralesional cidofovir be used for recurrent respiratory papillomatosis?
    Donne A; Rothera M; Homer J
    Clin Otolaryngol; 2010 Feb; 35(1):60. PubMed ID: 20447168
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].
    Snoeck R; Wellens W; Desloovere C; Van Ranst M; Naesens L; De Clercq E; Feenstra L
    J Med Virol; 1998 Mar; 54(3):219-25. PubMed ID: 9515772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Respiratory papillomatosis--new methods of treatment].
    Nowaczewska K; Wójtowicz P; Kukwa A; Ratajczak J; Tulibacki M
    Otolaryngol Pol; 2010; 64(1):31-6. PubMed ID: 20476590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
    Gupta HT; Robinson RA; Murray RC; Karnell LH; Smith RJ; Hoffman HT
    Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
    Lott DG; Krakovitz PR
    Laryngoscope; 2009 Mar; 119(3):567-70. PubMed ID: 19235765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon alpha-2b.
    Armbruster C; Kreuzer A; Vorbach H; Huber M; Armbruster C
    Eur Respir J; 2001 Apr; 17(4):830-1. PubMed ID: 11401080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children?
    Peyton Shirley W; Wiatrak B
    Int J Pediatr Otorhinolaryngol; 2004 Apr; 68(4):413-8. PubMed ID: 15013606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In reference to Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
    Preuss SF; Quante G
    Laryngoscope; 2010 Mar; 120(3):650; author reply 651. PubMed ID: 20013845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.